Diabetes Care 36 , 24152422 (2013)
Medications originally created to manage type 2 diabetes are now making headlines for their surprising impact on weight loss
Personalized Treatment With Precision Peptide Genetic Testing The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
N Engl J Med 377(1):1327 Wilding JPH et al (2021) Once-weekly semaglutide in adults with overweight or obesity
2012;129(3):e827-e841
Medical Considerations: Semaglutide or Tirzepatide, including micro-dose programs, cannot be prescribed and should not be purchased by individuals with a BMI under 25 (or under 20 for micro-dosing), an eating disorder, diabetes, gallbladder disease, history of drug or alcohol abuse, recent bariatric surgery, pancreatitis, medullary thyroid cancer or a family history of it, diabetic retinopathy, multiple endocrine neoplasia type 2, or those who are pregnant, breastfeeding, or planning to become pregnant